Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World's Largest Public Skin Cancer Image Databases to Accelerate AI Development
Medical Care Technologies (OTC Pink:MDCE) has secured access to the International Skin Imaging Collaboration (ISIC) Archive, one of the world's largest public skin cancer image databases. The archive contains over 70,000 dermoscopic images with expert annotations across various skin tones and cancer types.
This database will be used to train MDCE's AI software for detecting and classifying melanoma and other skin cancers. With skin cancer being the most common cancer globally (1.5 million new cases annually), this development aims to improve early detection capabilities worldwide.
The company is currently integrating the ISIC data into its machine learning pipeline and exploring additional collaborations to expand its training image database as it progresses toward clinical trials and commercialization.
Medical Care Technologies (OTC Pink:MDCE) ha ottenuto l'accesso all'ISIC Archive, una delle più grandi banche dati pubbliche di immagini della pelle al mondo. L'archivio contiene oltre 70.000 immagini dermatoscopiche con annotazioni esperte che coprono diverse tonalità di pelle e tipi di cancro.
Questo database sarà utilizzato per addestrare il software AI di MDCE per rilevare e classificare il melanoma e altri tumori della pelle. Poiché il cancro della pelle è il cancro più comune a livello globale (1,5 milioni di nuovi casi all'anno), questo sviluppo mira a migliorare la capacità di rilevamento precoce in tutto il mondo.
L'azienda sta attualmente integrando i dati ISIC nel proprio pipeline di machine learning e sta esplorando ulteriori collaborazioni per espandere il database di immagini di addestramento mentre procede verso studi clinici e la commercializzazione.
Medical Care Technologies (OTC Pink:MDCE) ha asegurado acceso al International Skin Imaging Collaboration (ISIC) Archive, una de las mayores bases de datos públicas de imágenes de cáncer de piel del mundo. El archivo contiene más de 70,000 imágenes dermoscópicas con anotaciones de expertos que abarcan diversos tonos de piel y tipos de cáncer.
Esta base de datos se utilizará para entrenar el software de IA de MDCE para detectar y clasificar el melanoma y otros cánceres de piel. Con el cáncer de piel siendo el cáncer más común a nivel mundial (1,5 millones de nuevos casos al año), este desarrollo pretende mejorar las capacidades de detección temprana en todo el mundo.
La empresa está integrando actualmente los datos ISIC en su pipeline de aprendizaje automático y explorando colaboraciones adicionales para ampliar su base de imágenes de entrenamiento a medida que avanza hacia ensayos clínicos y la comercialización.
의료 관리 기술(MDCE) OTC 핑크:MDCE는 국제 피부 이미징 협력(ISIC) 아카이브에 접근권을 확보했으며, 세계에서 가장 큰 공공 피부암 이미지 데이터베이스 중 하나입니다. 이 아카이브에는 70,000장이 넘는 피부진단 이미지가 전문가 주석과 함께 다양한 피부 톤과 암 유형을 커버합니다.
이 데이터베이스는 melanoma 및 기타 피부암을 감지하고 분류하기 위한 MDCE의 AI 소프트웨어를 학습시키는 데 사용될 것입니다. 피부암은 전 세계에서 가장 흔한 암으로(매년 150만 건의 신규 사례) 알려져 있으며, 이 개발은 전 세계적으로 조기 발견 능력을 향상시키는 것을 목표로 합니다.
회사는 현재 ISIC 데이터를 기계 학습 파이프라인에 통합하고 있으며 임상 시험 및 상용화를 향해 진행하는 동안 교육 이미지 데이터베이스를 확장하기 위한 추가 협력을 모색하고 있습니다.
Medical Care Technologies (OTC Pink:MDCE) a accès à l'International Skin Imaging Collaboration (ISIC) Archive, l'une des plus grandes bases de données publiques d'images de cancer de la peau au monde. L'archive contient plus de 70 000 images dermoscopiques avec des annotations d'experts couvrant une variété de tons de peau et de types de cancer.
Cette base de données sera utilisée pour entraîner le logiciel d'IA de MDCE afin de détecter et de classer le mélanome et d'autres cancers de la peau. Le cancer de la peau étant le cancer le plus répandu dans le monde (1,5 million de nouveaux cas annuels), ce développement vise à améliorer les capacités de détection précoce dans le monde entier.
L'entreprise intègre actuellement les données ISIC dans son pipeline d'apprentissage automatique et explore des collaborations supplémentaires pour étendre sa base d'images d'entraînement à mesure qu'elle progresse vers des essais cliniques et la commercialisation.
Medical Care Technologies (OTC Pink:MDCE) hat Zugriff auf das International Skin Imaging Collaboration (ISIC) Archive erhalten, eine der weltweit größten öffentlichen Bilddatenbanken für Hautkrebs. Das Archiv enthält über 70.000 dermatoskopische Bilder mit Expertenannotationen, die verschiedene Hauttypen und Krebsarten abdecken.
Diese Datenbank wird verwendet, um MDCEs KI-Software zum Erkennen und Klassifizieren von Melanomen und anderen Hautkrebsarten zu trainieren. Da Hautkrebs weltweit die häufigste Krebsform ist (1,5 Millionen neue Fälle pro Jahr), zielt diese Entwicklung darauf ab, die Möglichkeiten zur frühzeitigen Erkennung weltweit zu verbessern.
Das Unternehmen integriert derzeit die ISIC-Daten in seine maschinellen Lernpipeline und prüft zusätzliche Kooperationen, um seine Trainingsbild-Datenbank im Verlauf klinischer Studien und der Kommerzialisierung zu erweitern.
Medical Care Technologies (OTC Pink:MDCE) تمكّنت من الوصول إلى أرشيف ISIC، وهو أحد أكبر قواعد بيانات صور سرطان الجلد العامة في العالم. يحتوي الأرشيف على أكثر من 70,000 صورة تنظيرية للجلد مع تعليقات خبراء تغطي درجات لون بشرة ونُوعيات سرطانية مختلفة.
سيتم استخدام هذه القاعدة لتدريب برنامج الذكاء الاصطناعي لـMDCE للكشف عن الورم الميلانيني وأنواع أخرى من سرطان الجلد وتصنيفه.
نظرًا لكون سرطان الجلد هو أكثر أنواع السرطان شيوعًا في العالم (1,5 مليون حالة جديدة سنويًا)، يهدف هذا التطور إلى تحسين قدرات الكشف المبكر في جميع أنحاء العالم.
تقوم الشركة حاليًا بدمج بيانات ISIC في خطها لبرامج التعلم الآلي وتستكشف تعاونا إضافيا لتوسيع قاعدة بيانات صور التدريب مع تقدمها نحو التجارب السريرية والتسويق.
Medical Care Technologies (OTC Pink:MDCE) 已获得访问 International Skin Imaging Collaboration (ISIC) Archive 的权限，这是全球最大的公开皮肤癌图像数据库之一。该档案包含超过70,000 张皮肤镜图像，并由专家在不同肤色和癌症类型上进行注释。
该数据库将用于训练 MDCE 的 AI 软件，以检测和分类黑色素瘤及其他皮肤癌。由于皮肤癌是全球最常见的癌症之一（每年 150 万例新发），这一发展旨在提高全球的早期检测能力。
公司目前正在将 ISIC 数据整合到其机器学习管道中，并在推进临床试验与商业化的过程中寻求额外合作，以扩展其训练图像数据库。
- Access secured to prestigious ISIC Archive with 70,000+ expert-annotated dermoscopic images
- Strategic positioning for development of AI-driven skin cancer detection software
- Addresses large market opportunity with skin cancer being most common cancer globally (1.5M new cases/year)
- Positions company for future clinical trials and commercialization pathway
- Early stage development with no immediate revenue generation
- Clinical trials and regulatory approvals still pending
- Commercialization timeline undefined
MESA, ARIZONA / ACCESS Newswire / October 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of advanced healthcare AI solutions, today announced that it has secured access to the International Skin Imaging Collaboration (ISIC) Archive - one of the world's largest publicly available, biopsy-verified image repositories for skin cancer and related dermatological conditions.
The ISIC Archive contains more than 70,000 high-quality, expertly annotated dermoscopic images, representing a wide range of skin tones, cancer subtypes, and benign conditions. This unprecedented data resource will serve as a foundation for training MDCE's proprietary AI software designed to detect and classify melanoma and other skin cancers at a level approaching clinical accuracy.
"The medical AI community has long recognized the ISIC Archive as a gold standard for dermatology research," said Marshall Perkins III, CEO of Medical Care Technologies. "By leveraging this highly respected and globally validated dataset, MDCE is advancing its mission to make early detection of skin cancer faster, more accurate, and more accessible worldwide."
Skin cancer is the most common cancer globally, with more than 1.5 million new cases diagnosed each year. Early detection dramatically improves patient outcomes, but access to dermatologists and specialized diagnostic tools remains limited in many parts of the world.
MDCE's development program is currently focused on integrating the ISIC data into its machine learning pipeline, with additional collaborations under review to further expand the diversity and scope of training images.
This milestone positions Medical Care Technologies to progress toward future clinical trials, regulatory pathways, and eventual commercialization of its AI-driven diagnostic platform.
Company Website: www.medicalcaretechnologies.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink:MDCE) is a healthcare technology company dedicated to developing innovative medical software solutions that improve early disease detection and patient care outcomes. The company is currently advancing an artificial intelligence platform for skin cancer and dermatological condition identification.
Safe Harbor Statement
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, projections, and assumptions that involve risks and uncertainties which may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What is the significance of MDCE's access to the ISIC Archive for skin cancer detection?
How many skin cancer cases occur globally according to MDCE's press release?
What is Medical Care Technologies (MDCE) current development focus?
What are the next steps for MDCE's AI skin cancer detection platform?
How will MDCE's AI technology benefit skin cancer detection?
